| pubmed-article:9915317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C1185625 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0041657 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0682583 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:9915317 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:9915317 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9915317 | pubmed:dateCreated | 1999-2-4 | lld:pubmed |
| pubmed-article:9915317 | pubmed:abstractText | An effect compartment has been postulated, and the ke0 has been quantified for several intravenous anesthetic drugs using electroencephalography (EEG) as the measure of effect. The authors wanted to validate that loss of responsiveness (LOR) was related to targeting an effect compartment concentration rather than a central compartment (plasma) concentration. | lld:pubmed |
| pubmed-article:9915317 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9915317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9915317 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9915317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9915317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9915317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9915317 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:9915317 | pubmed:issn | 0003-3022 | lld:pubmed |
| pubmed-article:9915317 | pubmed:author | pubmed-author:HowellSS | lld:pubmed |
| pubmed-article:9915317 | pubmed:author | pubmed-author:ZimmermanJ... | lld:pubmed |
| pubmed-article:9915317 | pubmed:author | pubmed-author:GlassP SPS | lld:pubmed |
| pubmed-article:9915317 | pubmed:author | pubmed-author:WakelingH GHG | lld:pubmed |
| pubmed-article:9915317 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9915317 | pubmed:volume | 90 | lld:pubmed |
| pubmed-article:9915317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9915317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9915317 | pubmed:pagination | 92-7 | lld:pubmed |
| pubmed-article:9915317 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:meshHeading | pubmed-meshheading:9915317-... | lld:pubmed |
| pubmed-article:9915317 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:9915317 | pubmed:articleTitle | Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness? | lld:pubmed |
| pubmed-article:9915317 | pubmed:affiliation | Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA. | lld:pubmed |
| pubmed-article:9915317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9915317 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9915317 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9915317 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9915317 | lld:pubmed |
